Cargando…
How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases
Cardiovascular disease (CVD) causes millions of deaths worldwide each year. Despite the great progress in therapies available for patients with CVD, some limitations, including drug complications, still exist. Hence, the endocannabinoid system (ECS) was proposed as a new avenue for CVDs treatment. T...
Autores principales: | Dziemitko, Sylwia, Harasim-Symbor, Ewa, Chabowski, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830002/ https://www.ncbi.nlm.nih.gov/pubmed/36636553 http://dx.doi.org/10.1177/20406223221143239 |
Ejemplares similares
-
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
por: Bielawiec, Patrycja, et al.
Publicado: (2020) -
Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis
por: Bielawiec, Patrycja, et al.
Publicado: (2023) -
How Hypertension Affects Heart Metabolism
por: Polak-Iwaniuk, Agnieszka, et al.
Publicado: (2019) -
How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
por: Bzdęga, Wiktor, et al.
Publicado: (2023) -
Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD
por: Sztolsztener, Klaudia, et al.
Publicado: (2021)